unPAUSED with Dr. Mary Claire Haver Podcast Por Audacy | Mary Claire Haver MD arte de portada

unPAUSED with Dr. Mary Claire Haver

unPAUSED with Dr. Mary Claire Haver

De: Audacy | Mary Claire Haver MD
Escúchala gratis

Obtén 3 meses por US$0.99 al mes + $20 crédito Audible
Welcome to unPAUSED, the podcast where bold, unfiltered conversations take place about what it really takes for women to thrive in the second half of life. Every week, Dr. Mary Claire Haver, a board-certified Obstetrician-Gynecologist, Certified Menopause Practitioner, and #1 New York Times best-selling author, tackles the conversations women actually need to hear. Dr. Haver sits down with a variety of medical experts, CEOs, and risk-takers to discuss everything that matters, from hormones and identity to financial power, relationships, and the tools needed to build the life you want. unPAUSED is about reclaiming your healthspan—not just the number of years you live, but the number of years you live well. Tune in every Tuesday for new episodes of unPAUSED. Subscribe now so you don't miss it.Copyright © Mary Claire Media, LLC. All rights reserved. Ciencias Sociales Enfermedades Físicas Higiene y Vida Saludable
Episodios
  • GLP-1s and Midlife Metabolism: Dr. Rocio Salas-Whalen Breaks Down the Science of Weight Loss and Menopause: Part 1

    GLP-1s and Midlife Metabolism: Dr. Rocio Salas-Whalen Breaks Down the Science of Weight Loss and Menopause: Part 1
    Nov 11 2025
    Are GLP-1 medications a game-changer for women in midlife—or just another quick fix? In this conversation, triple board-certified endocrinologist Dr. Rocio Salas-Whalen joins Dr. Mary Claire Haver to cut through the hype and share what women really need to know about Ozempic, Wegovy, Mounjaro, and the science behind sustainable weight loss. Dr. Salas-Whalen, founder of New York Endocrinology and author of the upcoming book Weightless, explains why GLP-1 receptor agonists represent a fundamental shift in how we understand and treat obesity—not as a willpower problem, but as a chronic medical condition with biological drivers including hormones, genetics, and metabolism. For women navigating perimenopause and menopause, the conversation gets even more specific. Dr. Salas-Whalen breaks down why estrogen decline drives fat redistribution to the abdomen, increases visceral fat, and makes it nearly impossible to lose weight using the same strategies that worked before. She reveals how GLP-1 medications can address the metabolic changes of midlife while protecting what matters most: muscle mass. This episode covers: How GLP-1 medications work: mimicking gut hormones to regulate appetite, blood sugar, and metabolism Why 80% of women experience unexplained weight gain during perimenopause and menopause The difference between subcutaneous fat and visceral fat—and why it matters for heart health Dr. Salas-Whalen's GPS protocol: GLP-1 + Protein + Strength training to prevent muscle loss Why body composition matters more than BMI or the number on the scale How much muscle loss is acceptable during weight loss (and how to minimize it) The truth about "Ozempic face" Who should consider GLP-1 medications—and who shouldn't Common side effects, how to manage them, and what proper medical supervision looks like Why these medications may need to be long-term treatment for chronic obesity Dr. Salas-Whalen shares her clinical experience treating thousands of patients and addresses the viral misinformation circulating online. She explains why obesity is a transgenerational disease influenced by genetics, environment, food accessibility, and even childhood trauma—not personal failure. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices
    Más Menos
    1 h y 3 m
  • Build Strength, Live Longer: The Menopause Longevity Blueprint with Dr. Vonda Wright

    Build Strength, Live Longer: The Menopause Longevity Blueprint with Dr. Vonda Wright
    Nov 5 2025
    What if weak bones and muscle loss aren't just "normal aging" but the result of decades of misinformation? In this episode double board-certified orthopedic surgeon Dr. Vonda Wright joins Dr. Mary Claire Haver to shatter the myth that frailty, fractures, and decline are inevitable for women in midlife. Dr. Wright explains why women can lose up to 20% of their bone mass in just five years after menopause—and more importantly, what we can do to prevent it. She reveals how stress, inadequate nutrition, and neglecting strength training and hormonal health create the very outcomes we've been taught to accept as unavoidable. From the "musculoskeletal syndrome of menopause" that affects 70-80% of women (yet most doctors never discuss) to the science of building bones through strategic lifting, Dr. Wright provides the blueprint for aging with power instead of resignation. This episode also covers: Why your bones are master communicators affecting your brain, metabolism, and more The real story behind frozen shoulder and why it happens to women in perimenopause How to lift weights for longevity Why many women are diagnosed with osteoporosis only after they break something, when it's already too late How estrogen loss drives chronic inflammation Why nutrition, specifically foods that are rich in calcium, are better than calcium supplements to help strengthen bones Dr. Wright also shares her personal journey through perimenopause as an athlete and surgeon, and why she wrote her latest New York Times bestselling book Unbreakable. Guest links: Dr. Vonda Wright Dr. Vonda Wright (Instagram) Articles Longitudinal changes in bone mineral density during perimenopausal transition: the Vietnam Osteoporosis Study (Osteoporosis International) Osteoporosis Due to Hormone Imbalance: An Overview of the Effects of Estrogen Deficiency and Glucocorticoid Overuse on Bone Turnover (International Journal of Molecular Sciences) The musculoskeletal syndrome of menopause (Climacteric) Bone remodeling: an operational process ensuring survival and bone mechanical competence (Bone Research) Biological basis of bone strength: anatomy, physiology and measurement (J Musculoskelet Neuronal Interact) Stem Cells for the Regeneration of Tendon and Ligament: A Perspective (International Journal of Stem Cells) Peak bone mineral density in Vietnamese women (Archives of Osteoporosis) Sarcopenia: revised European consensus on definition and diagnosis (Age and Ageing) Sarcopenia (The Lancet) The Conceptual Definition of Sarcopenia: Delphi Consensus from the Global Leadership Initiative in Sarcopenia (GLIS) (Age and Ageing) Sarcopenia definition, diagnosis and treatment: consensus is growing (Age and Ageing) Poster 188: Is Hormone Replacing Therapy Associated with Reduced Risk of Adhesive Capsulitis in Menopausal Women? A Single Center Analysis (Orthopaedic Journal of Sports Medicine) A Narrative Review of Adhesive Capsulitis with Diabetes (Journal of Clinical Medicine) Women, men, and osteoarthritis (Arthritis Care and Research) Gender differences in health: results from SHARE, ELSA and HRS (European Journal of Public Health) The 2022 hormone therapy position statement of The North American Menopause Society (Menopause) The peri-menopause in a woman’s life: a systemic inflammatory phase that enables later neurodegenerative disease (Journal of Neuroinflammation) Vitamin D-Mediated Regulation of Intestinal Calcium Absorption (Nutrients) Prevention and treatment of osteoporosis in women (Post Reproductive Health) Impacts of protein quantity and distribution on body composition (Frontiers in Nutrition) To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices
    Más Menos
    1 h y 26 m
  • Menopause and Heart Disease: What Every Woman Needs to Know with Dr. Jayne Morgan

    Menopause and Heart Disease: What Every Woman Needs to Know with Dr. Jayne Morgan
    Oct 28 2025
    What if your hot flashes are actually warning signs about your cardiovascular health? Dr. Mary Claire Haver sits down with research cardiologist Dr. Jayne Morgan to talk about the intersection of menopause and heart disease. Dr. Morgan explains why women present with different heart attack symptoms than men, how menopause accelerates cardiovascular risk, and why the medical system still isn't recognizing the connection. You'll learn what hot flashes reveal about stroke and heart disease risk, how arterial stiffening and blood pressure changes happen during the menopause transition, and why hormone therapy started early may be protective for your heart. Dr. Morgan shares which lab tests women should be getting, when to start screening for cardiovascular disease, and what lifestyle changes actually make a difference. She also discusses the role of statins, GLP-1s, and why research done primarily on men has led to treatments that may harm women. This conversation covers what every woman needs to know about protecting her heart through midlife and beyond. Guest links: Dr. Jayne Morgan (Instagram) Dr. Jayne Morgan (YouTube) Dr. Jayne Morgan (TikTok) Healthy Her Series (AIB Network) Jayne Morgan, MD (LinkedIn) : Articles Improving Cardiovascular Clinical Competencies for the Menopausal Transition: A Focus on Cardiometabolic Health in Midlife (JACC Advances) Beta-blockers did not reduce cardiovascular events in selected heart attack patients in the REBOOT trial (European Society of Cardiology) Guidelines in Action: New Considerations for Primary Prevention of Stroke Related to Premature and Early Menopause (Stroke/American Heart Association) Risk of Cardiovascular Disease by Hysterectomy Status, With and Without Oophorectomy: The Women’s Health Initiative Observational Study (Circulation/American Heart Association) Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association (Circulation/American Heart Association) Emerging role of GLP-1 agonists in cardio-metabolic therapy - Focus on Semaglutide (American Heart Journal Plus: Cardiology Research and Practice) Other Resources Breast Cancer Foundation (Susan G. Komen) Dr. Stacy Sims (Dr. Stacy Sims - About) Symptoms of Coronary Heart Disease (NIH) Cardiac Biomarkers (NIH) Framingham Risk Score for Hard Coronary Heart Disease Gates Foundation Announces Catalytic Funding to Spark New Era of Women-Centered Research and Innovation (Gates Foundation) Advancing Postpartum Systems of Care Initiative (American Heart Association) Prevention (World Heart Federation) Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD (Lp(a)HORIZON) (Clinicaltrials.gov) Sleep Disorders and Heart Health (American Heart Association) To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices
    Más Menos
    1 h y 24 m
Todavía no hay opiniones